Literature DB >> 19002568

Insertion of the designed helical linker led to increased expression of tf-based fusion proteins.

Nurmamet Amet1, Hsin-Fang Lee, Wei-Chiang Shen.   

Abstract

PURPOSE: To demonstrate a high-level expression of transferrin (Tf)-based fusion proteins by inserting a helical linker between two protein domains.
METHODS: Tf-based fusion proteins were designed to contain oligonucleotides encoding a helical linker inserted between the protein domains. Plasmid constructs were transfected into HEK293 cells and the secreted fusion proteins were purified from conditioned serum free media. Expression was assessed using both SDS-PAGE and Western Blot using anti-hGH, G-CSF, or Tf antibodies; protein bands were analyzed using Quantity One software. The function of fusion proteins consisting of human growth hormone (hGH) and Tf was evaluated in Nb2 cell proliferation assays.
RESULTS: The fusion proteins containing a helical linker, hGH-(H4)(2)-Tf and Tf-(H4)(2)-hGH, were expressed 1.7-and 2.4-fold higher, respectively, with a twofold lower ED(50) than the hGH-Tf fusion protein without a helical linker. The Tf-(H4)(2)-G-CSF fusion protein exhibited a greater expression with an 11.2-fold increase compared with Tf-G-CSF fusion protein.
CONCLUSIONS: The helical linker introduced in Tf-fusion proteins resulted in a high-level of expression with improved in vitro bioactivity. This approach provides a simple method to increase poor expression of other fusion proteins.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19002568      PMCID: PMC3121561          DOI: 10.1007/s11095-008-9767-0

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  19 in total

1.  A novel specific bioassay for serum human growth hormone.

Authors:  M Ishikawa; A Nimura; R Horikawa; N Katsumata; O Arisaka; M Wada; M Honjo; T Tanaka
Journal:  J Clin Endocrinol Metab       Date:  2000-11       Impact factor: 5.958

Review 2.  Large-scale transient expression in mammalian cells for recombinant protein production.

Authors:  F Wurm; A Bernard
Journal:  Curr Opin Biotechnol       Date:  1999-04       Impact factor: 9.740

Review 3.  Production of recombinant protein therapeutics in cultivated mammalian cells.

Authors:  Florian M Wurm
Journal:  Nat Biotechnol       Date:  2004-11       Impact factor: 54.908

Review 4.  Protein therapeutics: a summary and pharmacological classification.

Authors:  Benjamin Leader; Quentin J Baca; David E Golan
Journal:  Nat Rev Drug Discov       Date:  2008-01       Impact factor: 84.694

5.  Conformations of variably linked chimeric proteins evaluated by synchrotron X-ray small-angle scattering.

Authors:  Ryoichi Arai; Willy Wriggers; Yukihiro Nishikawa; Teruyuki Nagamune; Tetsuro Fujisawa
Journal:  Proteins       Date:  2004-12-01

6.  Engineering of functional chimeric protein G-Vargula luciferase.

Authors:  Y Maeda; H Ueda; J Kazami; G Kawano; E Suzuki; T Nagamune
Journal:  Anal Biochem       Date:  1997-07-01       Impact factor: 3.365

7.  Optimizing the stability of single-chain proteins by linker length and composition mutagenesis.

Authors:  C R Robinson; R T Sauer
Journal:  Proc Natl Acad Sci U S A       Date:  1998-05-26       Impact factor: 11.205

8.  High-level expression of soluble protein in Escherichia coli using a His6-tag and maltose-binding-protein double-affinity fusion system.

Authors:  K D Pryor; B Leiting
Journal:  Protein Expr Purif       Date:  1997-08       Impact factor: 1.650

9.  Production and characterization of fusion proteins containing transferrin and nerve growth factor.

Authors:  E Park; R M Starzyk; J P McGrath; T Lee; J George; A J Schutz; P Lynch; S D Putney
Journal:  J Drug Target       Date:  1998       Impact factor: 5.121

10.  Helix stabilization by Glu-...Lys+ salt bridges in short peptides of de novo design.

Authors:  S Marqusee; R L Baldwin
Journal:  Proc Natl Acad Sci U S A       Date:  1987-12       Impact factor: 11.205

View more
  37 in total

1.  Design of an in vivo cleavable disulfide linker in recombinant fusion proteins.

Authors:  Xiaoying Chen; Yun Bai; Jennica L Zaro; Wei-Chiang Shen
Journal:  Biotechniques       Date:  2010-07       Impact factor: 1.993

2.  In silico designing, cloning, and heterologous expression of novel chimeric human B lymphocyte CD20 extra loop.

Authors:  Mahdi Fasihi-Ramandi; Jafar Amani; Ali-Hatef Salmanian; Seyed Mohammad Moazzeni; Kazem Ahmadi
Journal:  Tumour Biol       Date:  2016-06-27

3.  Application of molecular dynamics simulations to design a dual-purpose oligopeptide linker sequence for fusion proteins.

Authors:  Ehsan Rezaie; Mozafar Mohammadi; Amirhossein Sakhteman; Peyman Bemani; Sajjad Ahrari
Journal:  J Mol Model       Date:  2018-10-15       Impact factor: 1.810

Review 4.  Transferrin as a model system for method development to study structure, dynamics and interactions of metalloproteins using mass spectrometry.

Authors:  Igor A Kaltashov; Cedric E Bobst; Mingxuan Zhang; Rachael Leverence; Dmitry R Gumerov
Journal:  Biochim Biophys Acta       Date:  2011-06-25

5.  High-resolution mass spectrometry confirms the presence of a hydroxyproline (Hyp) post-translational modification in the GGGGP linker of an Fc-fusion protein.

Authors:  Chris Spahr; Kannan Gunasekaran; Kenneth W Walker; Stone D-H Shi
Journal:  MAbs       Date:  2017-05-16       Impact factor: 5.857

6.  Harnessing the unique structural properties of isolated α-helices.

Authors:  Carter J Swanson; Sivaraj Sivaramakrishnan
Journal:  J Biol Chem       Date:  2014-07-24       Impact factor: 5.157

Review 7.  Advances and challenges in analytical characterization of biotechnology products: mass spectrometry-based approaches to study properties and behavior of protein therapeutics.

Authors:  Igor A Kaltashov; Cedric E Bobst; Rinat R Abzalimov; Guanbo Wang; Burcu Baykal; Shunhai Wang
Journal:  Biotechnol Adv       Date:  2011-05-17       Impact factor: 14.227

Review 8.  Fusion protein linkers: property, design and functionality.

Authors:  Xiaoying Chen; Jennica L Zaro; Wei-Chiang Shen
Journal:  Adv Drug Deliv Rev       Date:  2012-09-29       Impact factor: 15.470

9.  Effect of linkers on immobilization of scFvs with biotin-streptavidin interaction.

Authors:  Svetlana P Ikonomova; Megan T Le; Neha Kalla; Amy J Karlsson
Journal:  Biotechnol Appl Biochem       Date:  2018-02-26       Impact factor: 2.431

10.  Human growth hormone-transferrin fusion protein for oral delivery in hypophysectomized rats.

Authors:  Nurmamet Amet; Wei Wang; Wei-Chiang Shen
Journal:  J Control Release       Date:  2009-09-15       Impact factor: 9.776

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.